<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03638596</url>
  </required_header>
  <id_info>
    <org_study_id>HSC20160425H</org_study_id>
    <secondary_id>5R01AA014988</secondary_id>
    <nct_id>NCT03638596</nct_id>
  </id_info>
  <brief_title>Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants</brief_title>
  <official_title>Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center at San Antonio</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study will evaluate the efficacy of contingency management (i.e., reinforcement&#xD;
      for avoiding heavy drinking) among adults arrested for drunk driving and who are at risk for&#xD;
      ongoing heavy drinking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individuals who have a drunk driving arrest and are at risk for ongoing heavy drinking will&#xD;
      be recruited to test the efficacy of contingency management for reducing alcohol use and&#xD;
      identifying mechanisms of change. We will recruit those arrested for drunk driving offenses,&#xD;
      â‰¥ 21 years of age, who at risk for ongoing heavy alcohol use and randomize them to one of two&#xD;
      groups: control or a contingency management. Participants experience 8 weekly assessments of&#xD;
      current alcohol use and other variables associated with changes in alcohol use.&#xD;
      Post-intervention, participants will return to the laboratory once per month at 3, 6, 9, and&#xD;
      12 months post-study entry for follow-up procedures to determine the mechanisms of drinking&#xD;
      behavior change.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Temporarily closed to enrollment&#xD;
  </why_stopped>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>random assignment to treatment and control arms</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent heavy drinking days</measure>
    <time_frame>8-weeks</time_frame>
    <description>Percent of days with estimated breath alcohol concentration .08% or higher or self-reported drinks &gt; 5 for men and &gt; 4 for women</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent drinking days</measure>
    <time_frame>8-weeks</time_frame>
    <description>Percent of days with any positive transdermal alcohol concentration &gt;.02 or any self-reported drinks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up percent heavy drinking days</measure>
    <time_frame>12-months</time_frame>
    <description>Self-reported drinks &gt; 5 for men and &gt; 4 for women</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Follow-up percent drinking days</measure>
    <time_frame>12-months</time_frame>
    <description>Any self-reported drinks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of alcohol biomarker</measure>
    <time_frame>Baseline to 8-weeks</time_frame>
    <description>Change in phosphatidylethanol (PEth) using an assay on a blood sample</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Drunk Driving</condition>
  <arm_group>
    <arm_group_label>Contingency Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Incentive delivery contingent upon maintaining transdermal alcohol concentration below cut-off</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Incentive delivery not contingent on transdermal alcohol concentration</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>Incentive provided for changing alcohol drinking patterns based on ankle monitor</description>
    <arm_group_label>Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Incentive provided is not contingent on alcohol drinking patterns based on ankle monitor</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  arrested for drunk driving offense&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  significant alcohol withdrawal symptoms&#xD;
&#xD;
          -  medical condition that would contraindicate participation (e.g., pregnancy, scheduled&#xD;
             surgery)&#xD;
&#xD;
          -  inability to comprehend the informed consent process or study instructions&#xD;
&#xD;
          -  presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium&#xD;
&#xD;
          -  incarceration&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald M Dougherty, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center San Antonio</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas Health Science Center San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 16, 2018</study_first_submitted>
  <study_first_submitted_qc>August 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2018</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alcohol Impaired Driving</keyword>
  <keyword>Driving While Intoxicated</keyword>
  <keyword>Driving Under the Influence</keyword>
  <keyword>Driving While Impaired</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

